10-Q Filing
Filing Information
| Form Type | 10-Q |
| Accession Number | 0000049071-22-000071 |
| Period End Date | 20220930 |
| Filing Date | 20221102 |
| Fiscal Year | 2022 |
| Fiscal Period | Q3 |
| XBRL Instance | hum-20220930_htm.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
80 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Receivables, allowance for doubtful accounts |
AllowanceForDoubtfulAccountsReceivableCurrent
|
$71.00M | USD | Point-in-time |
| Receivables, allowance for doubtful accounts |
AllowanceForDoubtfulAccountsReceivableCurrent
|
$83.00M | USD | Point-in-time |
| Preferred stock, par (in dollars per share) |
PreferredStockParOrStatedValuePerShare
|
$1.00 | USD | Point-in-time |
| Preferred stock, par (in dollars per share) |
PreferredStockParOrStatedValuePerShare
|
$1.00 | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$3.39B | USD | Point-in-time |
| Preferred stock, shares authorized (in shares) |
PreferredStockSharesAuthorized
|
10.00M | shares | Point-in-time |
| Preferred stock, shares authorized (in shares) |
PreferredStockSharesAuthorized
|
10.00M | shares | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$13.56B | USD | Point-in-time |
| Investment securities |
ShortTermInvestments
|
$13.19B | USD | Point-in-time |
| Preferred stock, shares issued (in shares) |
PreferredStockSharesIssued
|
0.00 | shares | Point-in-time |
| Preferred stock, shares issued (in shares) |
PreferredStockSharesIssued
|
0.00 | shares | Point-in-time |
| Investment securities |
ShortTermInvestments
|
$13.12B | USD | Point-in-time |
| Common stock, par (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.17 | USD | Point-in-time |
| Common stock, par (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.17 | USD | Point-in-time |
| Receivables, net of allowances of $71 in 2022 and $83 in 2021 |
ReceivablesNetCurrent
|
$1.61B | USD | Point-in-time |
| Receivables, net of allowances of $71 in 2022 and $83 in 2021 |
ReceivablesNetCurrent
|
$1.81B | USD | Point-in-time |
| Common stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
300.00M | shares | Point-in-time |
| Common stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
300.00M | shares | Point-in-time |
| Other current assets |
OtherAssetsCurrent
|
$6.49B | USD | Point-in-time |
| Other current assets |
OtherAssetsCurrent
|
$5.42B | USD | Point-in-time |
| Common stock, shares issued (in shares) |
CommonStockSharesIssued
|
198.65M | shares | Point-in-time |
| Total current assets |
AssetsCurrent
|
$33.71B | USD | Point-in-time |
| Common stock, shares issued (in shares) |
CommonStockSharesIssued
|
198.67M | shares | Point-in-time |
| Total current assets |
AssetsCurrent
|
$24.89B | USD | Point-in-time |
| Treasury stock, shares (in shares) |
TreasuryStockCommonShares
|
72.07M | shares | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$3.07B | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$3.22B | USD | Point-in-time |
| Treasury stock, shares (in shares) |
TreasuryStockCommonShares
|
69.85M | shares | Point-in-time |
| Long-term investment securities |
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
|
$375.00M | USD | Point-in-time |
| Long-term investment securities |
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
|
$780.00M | USD | Point-in-time |
| Equity method investments |
EquityMethodInvestments
|
$738.00M | USD | Point-in-time |
| Equity method investments |
EquityMethodInvestments
|
$141.00M | USD | Point-in-time |
| Goodwill |
Goodwill
|
$11.09B | USD | Point-in-time |
| Goodwill |
Goodwill
|
$9.10B | USD | Point-in-time |
| Other long-term assets |
OtherAssetsNoncurrent
|
$4.38B | USD | Point-in-time |
| Other long-term assets |
OtherAssetsNoncurrent
|
$3.63B | USD | Point-in-time |
| Total assets |
Assets
|
$44.36B | USD | Point-in-time |
| Total assets |
Assets
|
$50.77B | USD | Point-in-time |
| Benefits payable |
LiabilityForClaimsAndClaimsAdjustmentExpense
|
$8.76B | USD | Point-in-time |
| Benefits payable |
LiabilityForClaimsAndClaimsAdjustmentExpense
|
$8.29B | USD | Point-in-time |
| Benefits payable |
LiabilityForClaimsAndClaimsAdjustmentExpense
|
$8.14B | USD | Point-in-time |
| Benefits payable |
LiabilityForClaimsAndClaimsAdjustmentExpense
|
$9.24B | USD | Point-in-time |
| Trade accounts payable and accrued expenses |
AccountsPayableAndAccruedLiabilitiesCurrent
|
$6.77B | USD | Point-in-time |
| Trade accounts payable and accrued expenses |
AccountsPayableAndAccruedLiabilitiesCurrent
|
$4.51B | USD | Point-in-time |
| Book overdraft |
BookOverdraftLiability
|
$237.00M | USD | Point-in-time |
| Book overdraft |
BookOverdraftLiability
|
$326.00M | USD | Point-in-time |
| Unearned revenues |
ContractWithCustomerLiabilityCurrent
|
$6.01B | USD | Point-in-time |
| Unearned revenues |
ContractWithCustomerLiabilityCurrent
|
$254.00M | USD | Point-in-time |
| Short-term debt |
DebtCurrent
|
$1.95B | USD | Point-in-time |
| Short-term debt |
DebtCurrent
|
$2.80B | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$25.05B | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$15.33B | USD | Point-in-time |
| Long-term debt |
LongTermDebtNoncurrent
|
$10.54B | USD | Point-in-time |
| Long-term debt |
LongTermDebtNoncurrent
|
$7.80B | USD | Point-in-time |
| Other long-term liabilities |
OtherLiabilitiesNoncurrent
|
$1.60B | USD | Point-in-time |
| Other long-term liabilities |
OtherLiabilitiesNoncurrent
|
$2.38B | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$34.45B | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$28.25B | USD | Point-in-time |
| Preferred stock, $1 par; 10,000,000 shares authorized; none issued |
PreferredStockValue
|
- | USD | Point-in-time |
| Preferred stock, $1 par; 10,000,000 shares authorized; none issued |
PreferredStockValue
|
- | USD | Point-in-time |
| Common stock, $0.16 2/3 par; 300,000,000 shares authorized; 198,666,598 shares issued at September 30, 2022 and 198,648,742 shares at December 31, 2021 |
CommonStockValue
|
$33.00M | USD | Point-in-time |
| Common stock, $0.16 2/3 par; 300,000,000 shares authorized; 198,666,598 shares issued at September 30, 2022 and 198,648,742 shares at December 31, 2021 |
CommonStockValue
|
$33.00M | USD | Point-in-time |
| Capital in excess of par value |
AdditionalPaidInCapitalCommonStock
|
$3.08B | USD | Point-in-time |
| Capital in excess of par value |
AdditionalPaidInCapitalCommonStock
|
$3.23B | USD | Point-in-time |
| Retained earnings |
RetainedEarningsAccumulatedDeficit
|
$23.09B | USD | Point-in-time |
| Retained earnings |
RetainedEarningsAccumulatedDeficit
|
$25.61B | USD | Point-in-time |
| Accumulated other comprehensive (loss) income |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$42.00M | USD | Point-in-time |
| Accumulated other comprehensive (loss) income |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-1.47B | USD | Point-in-time |
| Treasury stock, at cost, 72,066,280 shares at September 30, 2022 and 69,846,758 shares at December 31, 2021 |
TreasuryStockCommonValue
|
$11.15B | USD | Point-in-time |
| Treasury stock, at cost, 72,066,280 shares at September 30, 2022 and 69,846,758 shares at December 31, 2021 |
TreasuryStockCommonValue
|
$10.16B | USD | Point-in-time |
| Noncontrolling interests |
MinorityInterest
|
$63.00M | USD | Point-in-time |
| Noncontrolling interests |
MinorityInterest
|
$23.00M | USD | Point-in-time |
| Total stockholders equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$16.32B | USD | Point-in-time |
| Total stockholders equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$16.10B | USD | Point-in-time |
| Total stockholders equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$16.28B | USD | Point-in-time |
| Total stockholders equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$15.51B | USD | Point-in-time |
| Total stockholders equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$13.73B | USD | Point-in-time |
| Total stockholders equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$14.84B | USD | Point-in-time |
| Total liabilities and stockholders equity |
LiabilitiesAndStockholdersEquity
|
$50.77B | USD | Point-in-time |
| Total liabilities and stockholders equity |
LiabilitiesAndStockholdersEquity
|
$44.36B | USD | Point-in-time |
Income Statement
80 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Premiums |
PremiumsEarnedNet
|
$21.47B | USD | 1 Quarter |
| Premiums |
PremiumsEarnedNet
|
$66.44B | USD | 3 Qtrs |
| Premiums |
PremiumsEarnedNet
|
$19.89B | USD | 1 Quarter |
| Premiums |
PremiumsEarnedNet
|
$59.99B | USD | 3 Qtrs |
| Services |
RevenueFromContractWithCustomerIncludingAssessedTax
|
$3.77B | USD | 3 Qtrs |
| Services |
RevenueFromContractWithCustomerIncludingAssessedTax
|
$1.16B | USD | 1 Quarter |
| Services |
RevenueFromContractWithCustomerIncludingAssessedTax
|
$845.00M | USD | 1 Quarter |
| Services |
RevenueFromContractWithCustomerIncludingAssessedTax
|
$1.80B | USD | 3 Qtrs |
| Investment income (loss) |
NetInvestmentIncome
|
$221.00M | USD | 3 Qtrs |
| Investment income (loss) |
NetInvestmentIncome
|
$222.00M | USD | 3 Qtrs |
| Investment income (loss) |
NetInvestmentIncome
|
$-33.00M | USD | 1 Quarter |
| Investment income (loss) |
NetInvestmentIncome
|
$172.00M | USD | 1 Quarter |
| Total revenues |
Revenues
|
$62.01B | USD | 3 Qtrs |
| Total revenues |
Revenues
|
$22.80B | USD | 1 Quarter |
| Total revenues |
Revenues
|
$20.70B | USD | 1 Quarter |
| Total revenues |
Revenues
|
$70.43B | USD | 3 Qtrs |
| Benefits |
PolicyholderBenefitsAndClaimsIncurredHealthCare
|
$17.32B | USD | 1 Quarter |
| Benefits |
PolicyholderBenefitsAndClaimsIncurredHealthCare
|
$57.11B | USD | 3 Qtrs |
| Benefits |
PolicyholderBenefitsAndClaimsIncurredHealthCare
|
$51.76B | USD | 3 Qtrs |
| Benefits |
PolicyholderBenefitsAndClaimsIncurredHealthCare
|
$18.38B | USD | 1 Quarter |
| Operating costs |
SellingGeneralAndAdministrativeExpense
|
$9.12B | USD | 3 Qtrs |
| Operating costs |
SellingGeneralAndAdministrativeExpense
|
$3.06B | USD | 1 Quarter |
| Operating costs |
SellingGeneralAndAdministrativeExpense
|
$2.60B | USD | 1 Quarter |
| Operating costs |
SellingGeneralAndAdministrativeExpense
|
$6.73B | USD | 3 Qtrs |
| Depreciation and amortization |
DepreciationAndAmortizationIncomeStatement
|
$527.00M | USD | 3 Qtrs |
| Depreciation and amortization |
DepreciationAndAmortizationIncomeStatement
|
$182.00M | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationAndAmortizationIncomeStatement
|
$436.00M | USD | 3 Qtrs |
| Depreciation and amortization |
DepreciationAndAmortizationIncomeStatement
|
$150.00M | USD | 1 Quarter |
| Total operating expenses |
BenefitsLossesAndExpenses
|
$66.75B | USD | 3 Qtrs |
| Total operating expenses |
BenefitsLossesAndExpenses
|
$20.07B | USD | 1 Quarter |
| Total operating expenses |
BenefitsLossesAndExpenses
|
$21.63B | USD | 1 Quarter |
| Total operating expenses |
BenefitsLossesAndExpenses
|
$58.92B | USD | 3 Qtrs |
| Income (loss) from operations |
OperatingIncomeLoss
|
$3.09B | USD | 3 Qtrs |
| Income (loss) from operations |
OperatingIncomeLoss
|
$628.00M | USD | 1 Quarter |
| Income (loss) from operations |
OperatingIncomeLoss
|
$1.17B | USD | 1 Quarter |
| Income (loss) from operations |
OperatingIncomeLoss
|
$3.68B | USD | 3 Qtrs |
| Gain on sale of KAH Hospice |
GainLossOnSaleOfBusiness
|
$240.00M | USD | 1 Quarter |
| Gain on sale of KAH Hospice |
GainLossOnSaleOfBusiness
|
- | USD | 1 Quarter |
| Gain on sale of KAH Hospice |
GainLossOnSaleOfBusiness
|
$240.00M | USD | 3 Qtrs |
| Gain on sale of KAH Hospice |
GainLossOnSaleOfBusiness
|
- | USD | 3 Qtrs |
| Interest expense |
InterestExpense
|
$88.00M | USD | 1 Quarter |
| Interest expense |
InterestExpense
|
$235.00M | USD | 3 Qtrs |
| Interest expense |
InterestExpense
|
$293.00M | USD | 3 Qtrs |
| Interest expense |
InterestExpense
|
$102.00M | USD | 1 Quarter |
| Other expense (income), net |
OtherNonoperatingIncomeExpense
|
$1.10B | USD | 1 Quarter |
| Other expense (income), net |
OtherNonoperatingIncomeExpense
|
$16.00M | USD | 3 Qtrs |
| Other expense (income), net |
OtherNonoperatingIncomeExpense
|
$562.00M | USD | 3 Qtrs |
| Other expense (income), net |
OtherNonoperatingIncomeExpense
|
$-13.00M | USD | 1 Quarter |
| Income (loss) before income taxes and equity in net earnings |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$1.64B | USD | 1 Quarter |
| Income (loss) before income taxes and equity in net earnings |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$3.64B | USD | 3 Qtrs |
| Income (loss) before income taxes and equity in net earnings |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$1.30B | USD | 1 Quarter |
| Income (loss) before income taxes and equity in net earnings |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$3.41B | USD | 3 Qtrs |
| Provision for income taxes |
IncomeTaxExpenseBenefit
|
$820.00M | USD | 3 Qtrs |
| Provision for income taxes |
IncomeTaxExpenseBenefit
|
$107.00M | USD | 1 Quarter |
| Provision for income taxes |
IncomeTaxExpenseBenefit
|
$536.00M | USD | 3 Qtrs |
| Provision for income taxes |
IncomeTaxExpenseBenefit
|
$120.00M | USD | 1 Quarter |
| Equity in net earnings |
IncomeLossFromEquityMethodInvestments
|
$3.00M | USD | 1 Quarter |
| Equity in net earnings |
IncomeLossFromEquityMethodInvestments
|
$1.00M | USD | 3 Qtrs |
| Equity in net earnings |
IncomeLossFromEquityMethodInvestments
|
$15.00M | USD | 1 Quarter |
| Equity in net earnings |
IncomeLossFromEquityMethodInvestments
|
$69.00M | USD | 3 Qtrs |
| Net income |
ProfitLoss
|
$1.53B | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$1.19B | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$2.95B | USD | 3 Qtrs |
| Net income |
ProfitLoss
|
$2.82B | USD | 3 Qtrs |
| Net loss attributable to noncontrolling interests |
NetIncomeLossAttributableToNoncontrollingInterest
|
- | USD | 3 Qtrs |
| Net loss attributable to noncontrolling interests |
NetIncomeLossAttributableToNoncontrollingInterest
|
- | USD | 1 Quarter |
| Net loss attributable to noncontrolling interests |
NetIncomeLossAttributableToNoncontrollingInterest
|
$-2.00M | USD | 1 Quarter |
| Net loss attributable to noncontrolling interests |
NetIncomeLossAttributableToNoncontrollingInterest
|
$-1.00M | USD | 3 Qtrs |
| Net income attributable to Humana |
NetIncomeLoss
|
$2.82B | USD | 3 Qtrs |
| Net income attributable to Humana |
NetIncomeLoss
|
$2.95B | USD | 3 Qtrs |
| Net income attributable to Humana |
NetIncomeLoss
|
$1.20B | USD | 1 Quarter |
| Net income attributable to Humana |
NetIncomeLoss
|
$1.53B | USD | 1 Quarter |
| Basic earnings per common share (in dollars per share) |
EarningsPerShareBasic
|
$11.91 | USD | 1 Quarter |
| Basic earnings per common share (in dollars per share) |
EarningsPerShareBasic
|
$22.27 | USD | 3 Qtrs |
| Basic earnings per common share (in dollars per share) |
EarningsPerShareBasic
|
$9.45 | USD | 1 Quarter |
| Basic earnings per common share (in dollars per share) |
EarningsPerShareBasic
|
$22.90 | USD | 3 Qtrs |
| Diluted earnings per common share (in dollars per share) |
EarningsPerShareDiluted
|
$22.16 | USD | 3 Qtrs |
| Diluted earnings per common share (in dollars per share) |
EarningsPerShareDiluted
|
$9.39 | USD | 1 Quarter |
| Diluted earnings per common share (in dollars per share) |
EarningsPerShareDiluted
|
$22.77 | USD | 3 Qtrs |
| Diluted earnings per common share (in dollars per share) |
EarningsPerShareDiluted
|
$11.84 | USD | 1 Quarter |
Cash Flow Statement
100 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net income |
ProfitLoss
|
$1.53B | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$1.19B | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$2.95B | USD | 3 Qtrs |
| Net income |
ProfitLoss
|
$2.82B | USD | 3 Qtrs |
| Gain on sale of KAH Hospice |
GainLossOnSaleOfBusiness
|
$240.00M | USD | 3 Qtrs |
| Gain on sale of KAH Hospice |
GainLossOnSaleOfBusiness
|
- | USD | 3 Qtrs |
| Gain on sale of KAH Hospice |
GainLossOnSaleOfBusiness
|
$240.00M | USD | 1 Quarter |
| Gain on sale of KAH Hospice |
GainLossOnSaleOfBusiness
|
- | USD | 1 Quarter |
| Loss on investment securities, net |
DebtSecuritiesAvailableForSaleRealizedGainLoss
|
$-136.00M | USD | 3 Qtrs |
| Loss on investment securities, net |
DebtSecuritiesAvailableForSaleRealizedGainLoss
|
$-18.00M | USD | 3 Qtrs |
| Gain on Kindred at Home equity method investment |
EquityMethodInvestmentRealizedGainLossOnDisposal
|
$1.13B | USD | 3 Qtrs |
| Gain on Kindred at Home equity method investment |
EquityMethodInvestmentRealizedGainLossOnDisposal
|
- | USD | 3 Qtrs |
| Equity in net earnings |
IncomeLossFromEquityMethodInvestments
|
$15.00M | USD | 1 Quarter |
| Equity in net earnings |
IncomeLossFromEquityMethodInvestments
|
$69.00M | USD | 3 Qtrs |
| Equity in net earnings |
IncomeLossFromEquityMethodInvestments
|
$1.00M | USD | 3 Qtrs |
| Equity in net earnings |
IncomeLossFromEquityMethodInvestments
|
$3.00M | USD | 1 Quarter |
| Stock-based compensation |
ShareBasedCompensation
|
$132.00M | USD | 3 Qtrs |
| Stock-based compensation |
ShareBasedCompensation
|
$173.00M | USD | 3 Qtrs |
| Depreciation |
Depreciation
|
$468.00M | USD | 3 Qtrs |
| Depreciation |
Depreciation
|
$555.00M | USD | 3 Qtrs |
| Amortization |
AdjustmentForAmortization
|
$73.00M | USD | 3 Qtrs |
| Amortization |
AdjustmentForAmortization
|
$51.00M | USD | 3 Qtrs |
| Impairment on property and equipment |
TangibleAssetImpairmentCharges
|
$144.00M | USD | 3 Qtrs |
| Impairment on property and equipment |
TangibleAssetImpairmentCharges
|
- | USD | 3 Qtrs |
| Deferred income taxes |
DeferredIncomeTaxExpenseBenefit
|
$-33.00M | USD | 3 Qtrs |
| Deferred income taxes |
DeferredIncomeTaxExpenseBenefit
|
- | USD | 3 Qtrs |
| Receivables |
IncreaseDecreaseInReceivables
|
$-11.00M | USD | 3 Qtrs |
| Receivables |
IncreaseDecreaseInReceivables
|
$294.00M | USD | 3 Qtrs |
| Other assets |
IncreaseDecreaseInOtherOperatingAssets
|
$476.00M | USD | 3 Qtrs |
| Other assets |
IncreaseDecreaseInOtherOperatingAssets
|
$465.00M | USD | 3 Qtrs |
| Benefits payable |
IncreaseDecreaseInHealthCareInsuranceLiabilities
|
$948.00M | USD | 3 Qtrs |
| Benefits payable |
IncreaseDecreaseInHealthCareInsuranceLiabilities
|
$573.00M | USD | 3 Qtrs |
| Other liabilities |
IncreaseDecreaseInOtherOperatingLiabilities
|
$-195.00M | USD | 3 Qtrs |
| Other liabilities |
IncreaseDecreaseInOtherOperatingLiabilities
|
$207.00M | USD | 3 Qtrs |
| Unearned revenues |
IncreaseDecreaseInContractWithCustomerLiability
|
$5.76B | USD | 3 Qtrs |
| Unearned revenues |
IncreaseDecreaseInContractWithCustomerLiability
|
$-84.00M | USD | 3 Qtrs |
| Other |
OtherOperatingActivitiesCashFlowStatement
|
$14.00M | USD | 3 Qtrs |
| Other |
OtherOperatingActivitiesCashFlowStatement
|
$30.00M | USD | 3 Qtrs |
| Net cash provided by operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$2.36B | USD | 3 Qtrs |
| Net cash provided by operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$9.71B | USD | 3 Qtrs |
| Proceeds from sale of KAH Hospice, net |
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
|
- | USD | 3 Qtrs |
| Proceeds from sale of KAH Hospice, net |
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
|
$2.71B | USD | 3 Qtrs |
| Acquisitions, net of cash and cash equivalents acquired |
PaymentsToAcquireBusinessesNetOfCashAcquired
|
$293.00M | USD | 3 Qtrs |
| Acquisitions, net of cash and cash equivalents acquired |
PaymentsToAcquireBusinessesNetOfCashAcquired
|
$3.96B | USD | 3 Qtrs |
| Purchases of property and equipment, net |
PaymentsToAcquirePropertyPlantAndEquipment
|
$862.00M | USD | 3 Qtrs |
| Purchases of property and equipment, net |
PaymentsToAcquirePropertyPlantAndEquipment
|
$945.00M | USD | 3 Qtrs |
| Purchases of investment securities |
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
$4.74B | USD | 3 Qtrs |
| Purchases of investment securities |
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
$6.57B | USD | 3 Qtrs |
| Proceeds from maturities of investment securities |
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
$1.21B | USD | 3 Qtrs |
| Proceeds from maturities of investment securities |
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
$2.10B | USD | 3 Qtrs |
| Proceeds from sales of investment securities |
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
|
$2.92B | USD | 3 Qtrs |
| Proceeds from sales of investment securities |
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
|
$1.98B | USD | 3 Qtrs |
| Net cash provided by (used in) investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$6.00M | USD | 3 Qtrs |
| Net cash provided by (used in) investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-6.45B | USD | 3 Qtrs |
| Receipts from contract deposits, net |
PaymentsForProceedsFromContractDeposits
|
$-605.00M | USD | 3 Qtrs |
| Receipts from contract deposits, net |
PaymentsForProceedsFromContractDeposits
|
$-3.79B | USD | 3 Qtrs |
| Proceeds from issuance of senior notes, net |
ProceedsFromIssuanceOfSeniorLongTermDebt
|
$2.98B | USD | 3 Qtrs |
| Proceeds from issuance of senior notes, net |
ProceedsFromIssuanceOfSeniorLongTermDebt
|
$744.00M | USD | 3 Qtrs |
| (Repayments) proceeds from issuance of commercial paper, net |
ProceedsFromRepaymentsOfCommercialPaper
|
$193.00M | USD | 3 Qtrs |
| (Repayments) proceeds from issuance of commercial paper, net |
ProceedsFromRepaymentsOfCommercialPaper
|
$-660.00M | USD | 3 Qtrs |
| Proceeds from term loan |
ProceedsFromNotesPayable
|
$500.00M | USD | 3 Qtrs |
| Proceeds from term loan |
ProceedsFromNotesPayable
|
- | USD | 3 Qtrs |
| Repayment of term loan |
RepaymentsOfNotesPayable
|
$2.00B | USD | 3 Qtrs |
| Repayment of term loan |
RepaymentsOfNotesPayable
|
$150.00M | USD | 3 Qtrs |
| Debt issue costs |
PaymentsOfDebtIssuanceCosts
|
$29.00M | USD | 3 Qtrs |
| Debt issue costs |
PaymentsOfDebtIssuanceCosts
|
$2.00M | USD | 3 Qtrs |
| Change in book overdraft |
IncreaseDecreaseInBookOverdrafts
|
$-89.00M | USD | 3 Qtrs |
| Change in book overdraft |
IncreaseDecreaseInBookOverdrafts
|
$-80.00M | USD | 3 Qtrs |
| Common stock repurchases |
PaymentsForRepurchaseOfCommonStock
|
$36.00M | USD | 3 Qtrs |
| Common stock repurchases |
PaymentsForRepurchaseOfCommonStock
|
$1.03B | USD | 3 Qtrs |
| Dividends paid |
PaymentsOfDividends
|
$263.00M | USD | 3 Qtrs |
| Dividends paid |
PaymentsOfDividends
|
$291.00M | USD | 3 Qtrs |
| Other |
ProceedsFromPaymentsForOtherFinancingActivities
|
$-13.00M | USD | 3 Qtrs |
| Other |
ProceedsFromPaymentsForOtherFinancingActivities
|
$3.00M | USD | 3 Qtrs |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$444.00M | USD | 3 Qtrs |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$3.73B | USD | 3 Qtrs |
| Increase (decrease) in cash and cash equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$-369.00M | USD | 3 Qtrs |
| Increase (decrease) in cash and cash equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$10.16B | USD | 3 Qtrs |
| Cash and cash equivalents at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$13.56B | USD | Point-in-time |
| Cash and cash equivalents at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$4.30B | USD | Point-in-time |
| Cash and cash equivalents at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$3.39B | USD | Point-in-time |
| Cash and cash equivalents at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$4.67B | USD | Point-in-time |
| Cash and cash equivalents at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$13.56B | USD | Point-in-time |
| Cash and cash equivalents at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$4.30B | USD | Point-in-time |
| Cash and cash equivalents at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$3.39B | USD | Point-in-time |
| Cash and cash equivalents at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$4.67B | USD | Point-in-time |
| Interest payments |
InterestPaidNet
|
$183.00M | USD | 3 Qtrs |
| Interest payments |
InterestPaidNet
|
$256.00M | USD | 3 Qtrs |
| Income tax payments, net |
IncomeTaxesPaidNet
|
$751.00M | USD | 3 Qtrs |
| Income tax payments, net |
IncomeTaxesPaidNet
|
$219.00M | USD | 3 Qtrs |
| Fair value of assets acquired, net of cash and cash equivalents acquired |
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
|
$9.57B | USD | 3 Qtrs |
| Fair value of assets acquired, net of cash and cash equivalents acquired |
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
|
$411.00M | USD | 3 Qtrs |
| Less: Fair value of liabilities assumed |
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
|
$3.23B | USD | 3 Qtrs |
| Less: Fair value of liabilities assumed |
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
|
$65.00M | USD | 3 Qtrs |
| Less: Noncontrolling interests acquired |
NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired
|
$22.00M | USD | 3 Qtrs |
| Less: Noncontrolling interests acquired |
NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired
|
$53.00M | USD | 3 Qtrs |
| Less: Remeasured existing Kindred at Home equity method investment |
NoncashOrPartNoncashAcquisitionRemeasurementOfEquityInvestment
|
$2.36B | USD | 3 Qtrs |
| Less: Remeasured existing Kindred at Home equity method investment |
NoncashOrPartNoncashAcquisitionRemeasurementOfEquityInvestment
|
- | USD | 3 Qtrs |
| Cash paid for acquired businesses, net of cash and cash equivalents acquired |
PaymentsToAcquireBusinessesNetOfCashAcquired
|
$293.00M | USD | 3 Qtrs |
| Cash paid for acquired businesses, net of cash and cash equivalents acquired |
PaymentsToAcquireBusinessesNetOfCashAcquired
|
$3.96B | USD | 3 Qtrs |
Stockholders Equity
48 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Balances |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$16.32B | USD | Point-in-time |
| Balances |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$16.10B | USD | Point-in-time |
| Balances |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$16.28B | USD | Point-in-time |
| Balances |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$15.51B | USD | Point-in-time |
| Balances |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$13.73B | USD | Point-in-time |
| Balances |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$14.84B | USD | Point-in-time |
| Net income |
ProfitLoss
|
$1.53B | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$1.19B | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$2.95B | USD | 3 Qtrs |
| Net income |
ProfitLoss
|
$2.82B | USD | 3 Qtrs |
| Distribution from (to) noncontrolling interest holders, net |
NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders
|
$3.00M | USD | 1 Quarter |
| Distribution from (to) noncontrolling interest holders, net |
NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders
|
$-1.00M | USD | 3 Qtrs |
| Sale of KAH Hospice |
NoncontrollingInterestDecreaseFromDeconsolidation
|
$11.00M | USD | 1 Quarter |
| Sale of KAH Hospice |
NoncontrollingInterestDecreaseFromDeconsolidation
|
$11.00M | USD | 3 Qtrs |
| Acquisition |
NoncontrollingInterestIncreaseFromBusinessCombination
|
$53.00M | USD | 3 Qtrs |
| Acquisition |
NoncontrollingInterestIncreaseFromBusinessCombination
|
$22.00M | USD | 3 Qtrs |
| Acquisition |
NoncontrollingInterestIncreaseFromBusinessCombination
|
$22.00M | USD | 1 Quarter |
| Acquisition |
NoncontrollingInterestIncreaseFromBusinessCombination
|
$53.00M | USD | 1 Quarter |
| Other comprehensive loss |
OtherComprehensiveIncomeLossNetOfTax
|
$-71.00M | USD | 1 Quarter |
| Other comprehensive loss |
OtherComprehensiveIncomeLossNetOfTax
|
$-416.00M | USD | 1 Quarter |
| Other comprehensive loss |
OtherComprehensiveIncomeLossNetOfTax
|
$-246.00M | USD | 3 Qtrs |
| Other comprehensive loss |
OtherComprehensiveIncomeLossNetOfTax
|
$-1.51B | USD | 3 Qtrs |
| Common stock repurchases |
TreasuryStockValueAcquiredCostMethod
|
$1.03B | USD | 3 Qtrs |
| Common stock repurchases |
TreasuryStockValueAcquiredCostMethod
|
$4.00M | USD | 1 Quarter |
| Common stock repurchases |
TreasuryStockValueAcquiredCostMethod
|
$3.00M | USD | 1 Quarter |
| Common stock repurchases |
TreasuryStockValueAcquiredCostMethod
|
$36.00M | USD | 3 Qtrs |
| Dividends and dividend equivalents |
DividendsCommonStockCash
|
$100.00M | USD | 1 Quarter |
| Dividends and dividend equivalents |
DividendsCommonStockCash
|
$91.00M | USD | 1 Quarter |
| Dividends and dividend equivalents |
DividendsCommonStockCash
|
$301.00M | USD | 3 Qtrs |
| Dividends and dividend equivalents |
DividendsCommonStockCash
|
$273.00M | USD | 3 Qtrs |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$132.00M | USD | 3 Qtrs |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$80.00M | USD | 1 Quarter |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$173.00M | USD | 3 Qtrs |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$48.00M | USD | 1 Quarter |
| Restricted stock unit vesting |
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
- | USD | 1 Quarter |
| Restricted stock unit vesting |
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
- | USD | 3 Qtrs |
| Restricted stock unit vesting |
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
- | USD | 3 Qtrs |
| Restricted stock unit vesting |
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
- | USD | 1 Quarter |
| Stock option exercises |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$9.00M | USD | 1 Quarter |
| Stock option exercises |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$3.00M | USD | 1 Quarter |
| Stock option exercises |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$22.00M | USD | 3 Qtrs |
| Stock option exercises |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$8.00M | USD | 3 Qtrs |
| Balances |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$13.73B | USD | Point-in-time |
| Balances |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$16.32B | USD | Point-in-time |
| Balances |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$16.10B | USD | Point-in-time |
| Balances |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$16.28B | USD | Point-in-time |
| Balances |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$15.51B | USD | Point-in-time |
| Balances |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$14.84B | USD | Point-in-time |
Comprehensive Income
40 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net income attributable to Humana |
NetIncomeLoss
|
$1.20B | USD | 1 Quarter |
| Net income attributable to Humana |
NetIncomeLoss
|
$1.53B | USD | 1 Quarter |
| Net income attributable to Humana |
NetIncomeLoss
|
$2.95B | USD | 3 Qtrs |
| Net income attributable to Humana |
NetIncomeLoss
|
$2.82B | USD | 3 Qtrs |
| Change in gross unrealized investment losses |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
$-590.00M | USD | 1 Quarter |
| Change in gross unrealized investment losses |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
$-247.00M | USD | 3 Qtrs |
| Change in gross unrealized investment losses |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
$-1.98B | USD | 3 Qtrs |
| Change in gross unrealized investment losses |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
$-63.00M | USD | 1 Quarter |
| Effect of income taxes |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
$-14.00M | USD | 1 Quarter |
| Effect of income taxes |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
$-455.00M | USD | 3 Qtrs |
| Effect of income taxes |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
$-56.00M | USD | 3 Qtrs |
| Effect of income taxes |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
$-135.00M | USD | 1 Quarter |
| Total change in unrealized investment losses, net of tax |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$-1.53B | USD | 3 Qtrs |
| Total change in unrealized investment losses, net of tax |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$-49.00M | USD | 1 Quarter |
| Total change in unrealized investment losses, net of tax |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$-455.00M | USD | 1 Quarter |
| Total change in unrealized investment losses, net of tax |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$-191.00M | USD | 3 Qtrs |
| Reclassification adjustment for net realized gains (losses) |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
|
$-50.00M | USD | 1 Quarter |
| Reclassification adjustment for net realized gains (losses) |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
|
$80.00M | USD | 3 Qtrs |
| Reclassification adjustment for net realized gains (losses) |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
|
$16.00M | USD | 1 Quarter |
| Reclassification adjustment for net realized gains (losses) |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
|
$-23.00M | USD | 3 Qtrs |
| Effect of income taxes |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
|
$19.00M | USD | 3 Qtrs |
| Effect of income taxes |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
|
$-11.00M | USD | 1 Quarter |
| Effect of income taxes |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
|
$4.00M | USD | 1 Quarter |
| Effect of income taxes |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
|
$-5.00M | USD | 3 Qtrs |
| Total reclassification adjustment, net of tax |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
|
$-39.00M | USD | 1 Quarter |
| Total reclassification adjustment, net of tax |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
|
$12.00M | USD | 1 Quarter |
| Total reclassification adjustment, net of tax |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
|
$61.00M | USD | 3 Qtrs |
| Total reclassification adjustment, net of tax |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
|
$-18.00M | USD | 3 Qtrs |
| Other comprehensive loss, net of tax |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
$-1.51B | USD | 3 Qtrs |
| Other comprehensive loss, net of tax |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
$-252.00M | USD | 3 Qtrs |
| Other comprehensive loss, net of tax |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
$-61.00M | USD | 1 Quarter |
| Other comprehensive loss, net of tax |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
$-416.00M | USD | 1 Quarter |
| Comprehensive income attributable to equity method investments |
ComprehensiveIncomeLossNetOfTaxAttributableToEquityMethodInvestments
|
- | USD | 1 Quarter |
| Comprehensive income attributable to equity method investments |
ComprehensiveIncomeLossNetOfTaxAttributableToEquityMethodInvestments
|
- | USD | 3 Qtrs |
| Comprehensive income attributable to equity method investments |
ComprehensiveIncomeLossNetOfTaxAttributableToEquityMethodInvestments
|
$-10.00M | USD | 1 Quarter |
| Comprehensive income attributable to equity method investments |
ComprehensiveIncomeLossNetOfTaxAttributableToEquityMethodInvestments
|
$6.00M | USD | 3 Qtrs |
| Comprehensive income attributable to Humana |
ComprehensiveIncomeNetOfTax
|
$1.31B | USD | 3 Qtrs |
| Comprehensive income attributable to Humana |
ComprehensiveIncomeNetOfTax
|
$779.00M | USD | 1 Quarter |
| Comprehensive income attributable to Humana |
ComprehensiveIncomeNetOfTax
|
$2.70B | USD | 3 Qtrs |
| Comprehensive income attributable to Humana |
ComprehensiveIncomeNetOfTax
|
$1.46B | USD | 1 Quarter |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.